The effect of blockade of κ-opioid receptors in the medial preoptic area on the luteinizing hormone surge in the proestrous rat

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 111-119

  Smith, Matthew J ^a   Gallo, Robert V ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

opioid receptor; Luteinizing hormone surge; Medial preoptic area; Nor binaltorphimine; Norepinephrine; Push pull perfusion

Indexed keywords

BIS(4 METHYL 1 HOMOPIPERAZINYLTHIOCARBONYL)DISULFIDE; KAPPA OPIATE RECEPTOR; LUTEINIZING HORMONE; NORADRENALIN; NORBINALTORPHIMINE; PENTOBARBITAL; PHENOXYBENZAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUTEINIZING HORMONE RELEASE; MEDIAL PREOPTIC AREA; NONHUMAN; OVULATION; PRIORITY JOURNAL; PROESTRUS; RADIOIMMUNOASSAY; RAT; RECEPTOR BLOCKING;

ANIMALS; FEMALE; LUTEINIZING HORMONE; NALTREXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; OVULATION; PREOPTIC AREA; PROESTRUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SECRETORY RATE;

EID: 0030798717     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00622-7     Document Type: Article

References (43)

1. Allen L.G., Kalra S.P. Evidence that a decrease in opioid tone may evoke preovulatory luteinizing hormone release in the rat. Endocrinology. 118:1986;2375-2381.
2. Allen L.G., Hahn E., Caton D., Kalra S.P. Evidence that a decrease in opioid tone on proestrus changes the episodic pattern of luteinizing hormone (LH) secretion: implications in the preovulatory LH hypersecretion. Endocrinology. 122:1988;1004-1013.
3. Bohler H.C.L., Tracer H., Merriam G.R., Petersen S.L. Changes in proopiomelanocortin messenger ribonucleic acid levels in the rostral periarcuate region of the female rat during the estrous cycle. Endocrinology. 128:1991;1265-1269.
4. Chavkin C., Goldstein A. Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. USA. 78:1981;6543-6547.
5. Chavkin C., James I.F., Goldstein A. Dynorphin is a specific endogenous ligand of the κ opioid receptor. Science. 215:1981;413-415.
6. Corrodi H., Fuxe K., Hamberger L., Ljungdahl A. Studies on central and peripheral noradrenaline neurons using a new dopamine β-hydroxylase inhibitor. Eur. J. Pharmacol. 12:1970;145-155.
7. J. deGroot, The Rat Forebrain in Stereotaxic Coordinates, North Holland Publ., Amsterdam, 1959, pp. 1-40.
8. 1-adrenergic receptor involvement in the LH surge in ovariectomized estrogen-primed rats. Eur. J. Pharmacol. 81:1982;341-344.
9. J.W. Everett, Preoptic stimulative lesions and ovulation in the rat: 'Thresholds' and LH-release time in late diestrus and proestrus, in: E. Bajusz, G. Jasmin (Eds.), Major Problems in Neuroendocrinology, S. Karger, Basel, 1964, pp. 346-366.
10. Everett J.W., Sawyer C.H. A 24-hour periodicity in the 'LH-release apparatus' of female rats disclosed by barbiturate sedation. Endocrinology. 47:1950;198-218.
11. Gallo R.V. Pulsatile LH release during periods of low level LH secretion in the rat estrous cycle. Biol. Reprod. 24:1981;771-777.
12. Gallo R.V., Kalra P.S. Pulsatile LH release on diestrus 1 in the rat estrous cycle: relation to brain catecholamines and ovarian steroid secretion. Neuroendocrinology. 37:1983;91-97.
13. G.E. Hoffman, M.D. Fitzsimmons, R.E. Watson Jr., Relationship of endogenous opioid peptide axons to GnRH neurons in the rat, in: R.G. Dyer, R.J. Bicknell (Eds.), Brain Opioid Systems in Reproduction, Oxford University Press, Oxford, 1989, pp. 125-134.
14. Ito E., Mirzuno T., Kimura F. Effects of dynorphin on noradrenaline release in the rat medial preoptic area. Neuroendocrinology. P3.36:1994;71.
15. 3H-naloxone) binding are associated with the progesterone-induced LH surge. Endocrinology. 124:1989;199-206.
16. Kalra S.P. Mandatory neuropeptide-steroid signalling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocrine Rev. 14:1993;507-538.
17. Kinoshita F., Nakai Y., Katakami H., Imura H. Suppressive effect of dynorphin (1-13) on luteinizing hormone release in conscious castrated rats. Life Sci. 30:1982;1915-1919.
18. C. Kordon, S.V. Drouva, G. Martinez de la Escalera, R.I. Weiner, Role of classic and peptide neuromediators in the neuroendocrine regulation of LH and prolactin, in: E. Knobil, J.D. Neill (Eds.), The Physiology of Reproduction, Raven Press, New York, 1994, pp. 1621-1681.
19. 3H]DMI binding is associated with neuronal noradrenaline uptake in the periphery and the central nervous system. Eur. J. Pharmacol. 72:1981;423-424.
20. Leadem C.A., Kalra S.P. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats. Neuroendocrinology. 41:1985;342-352.
21. Maggi R., Dondi D., Rovati G.E., Martini L., Piva F., Limonti P. Binding characteristics of hypothalamic μ opioid receptors throughout the estrous cycle in the rat. Neuroendocrinology. 58:1993;366-372.
22. Mallory D.S., Bona-Gallo A., Gallo R.V. Neurotransmitter involvement in naloxone-induced stimulation of pulsatile LH release on day 8 of pregnancy in the rat. Brain Res. Bull. 22:1989;1015-1021.
23. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
24. Mohankumar P.S., Thyagarajan S., Quadri S.K. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging. Endocrinology. 135:1994;119-126.
25. M. Nickerson, B. Collier, Drugs inhibiting adrenergic neurons and structures innervated by them, in: L.S. Goodman, A. Gilman (Eds.), The Pharmacological Basis of Therapeutics, 5th ed., MacMillan, New York, 1975, pp. 533-564.
26. 131. Proc. Soc. Exp. Biol. Med. 128:1968;807-811.
27. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 40:1987;1287-1292.
28. Rance N., Wise P.M., Selmanoff M.K., Barraclough C.A. Catecholamine turnover rates in discrete hypothalamic areas and associated changes in median eminence luteinizing hormone-releasing hormone and serum gonadotropins on proestrus and diestrous day 1. Endocrinology. 108:1981;1795-1802.
29. 14C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. Acta Pharmacol. Toxicol. 36:1975;395-408.
30. Sarkar D.K., Yen S.S.C. Changes in β-endorphin-like immunoreactivity in pituitary portal blood during the estrous cycle and after ovariectomy in rats. Endocrinology. 116:1985;2075-2079.
31. Schulz R., Wilhelm A., Pirke K.M., Gramsch C., Herz A. β-Endorphin and dynorphin control serum luteinizing hormone level in immature female rats. Nature. 294:1981;757-759.
32. Thomas D.N., Holman R.B. A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J. Neurochem. 56:1991;1741-1746.
33. Tortella F.C., Echevarria E., Lipkowski A.W., Takemori A.E., Portoghese P.S., Holaday J.W. Selective κ antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci. 44:1989;661-665.
34. Werling L.L., Brown S.R., Cox B.M. Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology. 26:1987;987-996.
35. Werling L.L., MacMahon P.N., Portoghese P.S., Takemori A.E., Cox B.M. Selective opioid antagonist effects on opioid-induced-inhibition of release of norepinephrine in guinea pig cortex. Neuropharmacology. 28:1989;103-107.
36. Wise P.M., Rance N., Barraclough C.A. Effects of estradiol and progesterone on catecholamine turnover rates in discrete hypothalamic regions in ovariectomized rats. Endocrinology. 108:1981;2186-2193.
37. Wise P.M., Scarborough K., Wieland N.G., Larson G.H. Diurnal pattern of proopiomelanocortin gene expression in the arcuate nucleus of proestrous, ovariectomized and steroid-treated rats: a possible role in cyclic luteinizing hormone secretion. Mol. Endocrinology. 4:1990;886-892.
38. Witkin J.W., Paden C.M., Silverman A.-J. The luteinizing hormone-releasing hormone (LHRH) systems in the rat brain. Neuroendocrinology. 35:1982;429-438.
39. Wolfe A.M., Porka-Heiskanen T., Norgle J.R., Levine J.E. Evidence that norepinephrine release in the preoptic area does not mediate effects of opiate receptor antagonism of LH secretion: an in vivo microdialysis study. Soc. Neurosci. Abstr. 131.4:1993;311.
40. Zamir N., Palkovits M., Brownstein M.J. Distribution of immunoreactive dynorphin in the central nervous system of the rat. Brain Res. 280:1983;81-93.
41. Zhen S., Gallo R.V. The effect of blockade of κ-opioid receptors in the medial basal hypothalamus and medial preoptic area on luteinizing hormone release during midpregnancy in the rat. Endocrinology. 131:1992;1650-1656.
42. Zhen S., Gallo R.V. Lack of catecholamine involvement in the increased luteinizing hormone release due to blockade of κ-opioid receptors in the medial basal hypothalamus during midpregnancy in the rat. Brain Res. 642:1994;178-184.
43. Zhen S., Gallo R.V. The role of norepinephrine in mediating luteinizing hormone release in response to blockade of κ-opioid receptors in the medial preoptic area. Brain Res. 698:1995;121-129.